SCHEMBL6180951

SCHEMBL6180951

CCOC(=O)Oc1cc([N+](=O)[O-])c[nH]1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.43
CACNA1C Q13936 3/20 0.41
CACNA1F O60840 2/20 0.41
CACNA1D Q01668 2/20 0.41
CACNA1S Q13698 2/20 0.41
ADORA3 P0DMS8 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MAPT P10636 2/20 0.40
GLO1 Q04760 1/20 0.40
KMT2A Q03164 2/20 0.39
ALDH1A1 P00352 1/20 0.39
NQO2 P16083 1/20 0.39
HIF1A Q16665 2/20 0.39
MEN1 O00255 1/20 0.39
LMNA P02545 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27881201 0.80 ALDH1A1 (0.42) SMN1; SMN2MAPTGLO1KMT2AALDH1A1
SCHEMBL1299290 0.76 MAPT (0.53) NPC1CACNA1CCACNA1FCACNA1DCACNA1S
Ammonia Solution, Strong SCHEMBL2237158 0.75 MAPT (0.52) NPC1CACNA1CCACNA1FCACNA1DCACNA1S
SCHEMBL3943559 0.74 CYP19A1 (0.47) CACNA1CCACNA1FCACNA1DCACNA1SADORA3
SCHEMBL20640075 0.73 ALDH1A1 (0.45) NPC1CACNA1CCACNA1FCACNA1DCACNA1S
SCHEMBL278663 0.72 BCL9 (0.62) NPC1SMN1; SMN2MAPTKMT2AALDH1A1
SCHEMBL18886860 0.72 AR (0.39) NPC1CACNA1CCACNA1FCACNA1DCACNA1S
SCHEMBL5724604 0.71 CA12 (0.42) SMN1; SMN2MAPTKMT2AALDH1A1MEN1
SCHEMBL1695212 0.70 KMT2A (0.57) NPC1SMN1; SMN2MAPTKMT2AALDH1A1
SCHEMBL4611975 0.70 NPC1 (0.42) NPC1CACNA1CCACNA1FCACNA1DCACNA1S

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2948454-B1 TRIAZINE COMPOUNDS AND A PROCESS FOR PREPARATION THEREOF COUNCIL OF SCIENT & IND RES AN INDIAN REGISTERED BODY INCORPORATED UNDER THE REGISTRATION OF SOCIETI (IN) 2017-05-31 EP claimed
EP-1572642-A1 3-PYRROLYL UREA DERIVATIVES AND THEIR USE AS ANTIVIRAL AGENTS Bayer HealthCare AG (DE) 2005-09-14 EP disclosed
EP-1465613-A2 COMBINATION OF MTP INHIBITORS OR APOB SECRETION INHIBITORS WITH FIBRATES FOR USE AS DRUGS Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2004-10-13 EP disclosed
WO-2004052852-A1 3-PYRROLYL UREA DERIVATIVES AND THEIR USE AS ANTIVIRAL AGENTS BAYER HEALTHCARE AG (DE) 2004-06-24 WO disclosed
WO-2003057205-A2 COMBINATION OF MTP INHIBITORS OR APOB SECRETION INHIBITORS WITH FIBRATES FOR USE AS DRUGS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2003-07-17 WO disclosed
WO-2003004020-A1 HETEROARYL CARBOXYLIC ACID AMIDES, THE PRODUCTION THEREOF AND THE USE OF THE SAME AS INHIBITORS OF THE MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN (MTP) BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2003-01-16 WO disclosed